SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-002581
Filing Date
2020-03-13
Accepted
2020-03-13 08:16:17
Documents
10
Period of Report
2020-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 41612
2 PRE-FUNDED WARRANT tenx_ex41.htm EX-4.1 111322
3 UNREGISTERED WARRANT tenx_ex42.htm EX-4.2 118850
4 FORM OF PLACEMENT AGENT WARRANT tenx_ex43.htm EX-4.3 122873
5 LEGAL OPINION OF K&L GATES LLP tenx_ex51.htm EX-5.1 17706
6 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF MARCH 11, 2020, BY AND BETWEE tenx_ex101.htm EX-10.1 277099
7 PRESS RELEASE, DATED MARCH 12, 2020, REGARDING OFFERINGS tenx_ex991.htm EX-99.1 11516
8 PRESS RELEASE, DATED MARCH 12, 2020, REGARDING CLINICAL TRIAL tenx_ex992.htm EX-99.2 16419
9 IMAGE logo.jpg GRAPHIC 6280
10 IMAGE logo2.jpg GRAPHIC 1734
  Complete submission text file 0001654954-20-002581.txt   730260
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 20710778
SIC: 8731 Services-Commercial Physical & Biological Research